Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 17.6.2025Egis Pharmaceuticals PLC (EGI)2791BKetilept Prolong 50 mg tablety s predĺženým uvoľňovaním (tbl plg 60x50 mg (blis.PVC/PCTFE/Al))20.6.2025R
 17.6.2025Vipharm S.A. (VIH-PL-1)2359EAnvildis Duo 50 mg/850 mg filmom obalené tablety (tbl flm 60x50 mg/850 mg (blis.OPA/Al/PVC/Al))13.6.2025O
 17.6.2025Recordati Industria Chimica e Farmaceutica S.p.A. (REC-1)3191EEligard 22,5 mg (plv iol 1x22,5 mg+1x solv. (striek.inj.napl."A"+striek.inj.napl."B"+ihla+konektor))17.6.2025R
 16.6.2025Teva B.V. (TEV-NL-4)02078Trimetazidin Teva PR 35 mg (tbl plg 60x35 mg (blis.PVC/PVDC/Al))5.6.2025Z
 16.6.2025Olikla s.r.o. (OLK)7590ENitrofurantoin Olikla 100 mg tvrdé kapsuly (cps dur 30x100 mg ((blis.Al s povl.VMCH (25 mikr.) a PVC nepr.fil. (250 mikr.)))13.6.2025U
 16.6.2025Olikla s.r.o. (OLK)7588ENitrofurantoin Olikla 50 mg tvrdé kapsuly (cps dur 30x50 mg ((blis.Al s povl.VMCH (25 mikr.) a PVC nepr.fil. (250 mikr.)))13.6.2025U
 16.6.2025Pfizer Europe MA EEIG (PFI-BE-3)96122DAUNOBLASTINA (plv iol 1x20 mg+1x10 ml solv. (liek.inj.skl.))16.6.2025R
 16.6.2025Zakłady Farmaceutyczne Polpharma S.A. (ZAY)94763Naloxone Polpharma (sol inj 10x0,4 mg/1 ml (amp.skl.))16.6.2025R
 16.6.2025Pfizer Europe MA EEIG (PFI-BE-3)4345ELitfulo 50 mg tvrdé kapsuly (cps dur 30x50 mg (blis.OPA/Al/PVC/Al))13.6.2025U
 16.6.2025Egis Pharmaceuticals PLC (EGI)01328Dopegyt (tbl 50x250 mg)12.6.2025O
 13.6.2025Teva B.V. (TEV-NL-4)5524ETikagrelor Teva 90 mg (tbl flm 56x1x90 mg (blis.PVC/PVDC-Al - jednotk.kalend.bal.))3.6.2025U
 13.6.2025Teva B.V. (TEV-NL-4)95214Ramipril H 2,5 mg/12,5 mg Actavis (tbl 30x2,5 mg/12,5 mg (blis.Al/Al))4.6.2025O
 13.6.2025ratiopharm GmbH (RAT)36310Fentanyl ratiopharm 75 µg/h (emp tdm 5x75 µg/1 h (vre.papier/PE/Al/surlyn))4.6.2025O
 13.6.2025Teva B.V. (TEV-NL-4)58793Ecobec 250 µg (aer ora 200x250 µg/1 dávka (obal Al tlak.+aplik.))4.6.2025O
 13.6.2025Teva B.V. (TEV-NL-4)0512EAtorvastatín/Ezetimib Teva 80 mg/10 mg (tbl flm 100(2x50)x80 mg/10 mg (blis.OPA/Al/PVC/Al-multibal.))6.6.2026O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)